Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups

Publisher： Karger

E-ISSN： 1421-9662|133|4|372-380

ISSN： 0001-5792

Source： Acta Haematologica, Vol.133, Iss.4, 2015-03, pp. : 372-380

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does Low-Molecular-Weight Heparin Reduce the Costs of Venous Thromboembolism Treatment?

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 136-140

Karger

Access to resources Recommend Favorite

Effect of Low-Molecular-Weight Heparin on Potassium Homeostasis

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 3, 2002-10 ,pp. : 107-110

Karger

Access to resources Recommend Favorite

Antithrombotic drugs in acutely ill medical patients: review and meta-analysis of interventional trials with low-molecular-weight heparin and fondaparinux

By Loffredo Lorenzo   Perri Ludovica   Catasca Elisa   Del Ben Maria   Angelico Francesco   Violi Francesco  

Clinical Practice, Vol. 10, Iss. 5, 2013-09 ,pp. : 615-627

Future Medicine

Access to resources Recommend Favorite

Low-Molecular-Weight Heparin and Cancer Survival: Review of the Literature and Pooled Analysis of 1,726 Patients Treated for at Least Three Months

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 33, Iss. 4, 2004-12 ,pp. : 197-201

Karger

Access to resources Recommend Favorite

Comparison between Fondaparinux and Low-Molecular-Weight Heparin in Patients with Acute Coronary Syndrome: A Meta-Analysis

By  

Cardiology, Vol. 133, Iss. 3, 2016-0 ,pp. : 163-172

Karger

Access to resources Recommend Favorite